TAT (tyrosine aminotransferase)

2003-02-01  

Identity

HGNC
LOCATION
16q22.2
LOCUSID
ALIAS
-
FUSION GENES

Other Information

Locus ID:

NCBI: 6898
MIM: 613018
HGNC: 11573
Ensembl: ENSG00000198650

Variants:

dbSNP: 6898
ClinVar: 6898
TCGA: ENSG00000198650
COSMIC: TAT

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000198650ENST00000355962P17735
ENSG00000198650ENST00000355962A0A140VKB7

Expression (GTEx)

0
50
100
150
200
250
300
350
400
450
500

Pathways

PathwaySourceExternal ID
Ubiquinone and other terpenoid-quinone biosynthesisKEGGko00130
Tyrosine metabolismKEGGko00350
Phenylalanine metabolismKEGGko00360
Phenylalanine, tyrosine and tryptophan biosynthesisKEGGko00400
Ubiquinone and other terpenoid-quinone biosynthesisKEGGhsa00130
Tyrosine metabolismKEGGhsa00350
Phenylalanine metabolismKEGGhsa00360
Phenylalanine, tyrosine and tryptophan biosynthesisKEGGhsa00400
Cysteine and methionine metabolismKEGGko00270
Cysteine and methionine metabolismKEGGhsa00270
Metabolic pathwaysKEGGhsa01100
Methionine salvage pathwayKEGGhsa_M00034
Methionine salvage pathwayKEGGM00034
Biosynthesis of amino acidsKEGGhsa01230
Biosynthesis of amino acidsKEGGko01230
MetabolismREACTOMER-HSA-1430728
Metabolism of amino acids and derivativesREACTOMER-HSA-71291
Phenylalanine and tyrosine catabolismREACTOMER-HSA-71182
Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolismREACTOMER-HSA-6788656

References

Pubmed IDYearTitleCitations
386974622024TRIM21-mediated ubiquitylation of TAT suppresses liver metastasis in gallbladder cancer.0
386974622024TRIM21-mediated ubiquitylation of TAT suppresses liver metastasis in gallbladder cancer.0
368938722023Most synonymous allelic variants in HIV tat are not silent.1
368938722023Most synonymous allelic variants in HIV tat are not silent.1
282559852017Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation.9
282559852017Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation.9
272859492016Tyrosinemia type II: Novel mutations in TAT in a boy with unusual presentation.2
272859492016Tyrosinemia type II: Novel mutations in TAT in a boy with unusual presentation.2
239542272013Novel and recurrent mutations in the TAT gene in Tunisian families affected with Richner-Hanhart syndrome.5
239542272013Novel and recurrent mutations in the TAT gene in Tunisian families affected with Richner-Hanhart syndrome.5
216363002011A large TAT deletion in a tyrosinaemia type II patient.1
216363002011A large TAT deletion in a tyrosinaemia type II patient.1
202096012010Down-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma.27
202096012010Down-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma.27
187211272009Genetically modified adenoviral vector with the protein transduction domain of Tat improves gene transfer to CAR-deficient cells.3

Citation

Dessen P

TAT (tyrosine aminotransferase)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/42472/js/js/welcome